Novo Nordisk has signed off on a $285 million biobucks deal with fellow Denmark-based company Ascendis Pharma to help the Wegovy manufacturer develop a once-monthly GLP-1 receptor agonist.
Since there are no fixed returns in SIP investment, we are calculating as per annualised returns of 8 per cent (debt fund), 10 per cent (hybrid fund) and 12 per cent (equity fund) Magic of Compounding ...
You know what’s coming in and what’s going out, which can help you create financial stability. Although creating a budget may sound a little complicated, you may just need to know where to start.
The latest payrolls figure marked the fewest monthly job gains since December 2020, during the depths of the Covid pandemic, with the Bureau of Labor Statistics saying the U.S. effectively added ...
Availability: Some of these dairy-free advent calendars won’t be available until November 1st, the day after Halloween. We’re updating a little early this year because most companies sell out quickly!